Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Vaxart Gets FDA Sign-Off on Phase 1 Clinical Trial for Its Coronavirus Vaccine
07:17pm, Monday, 14'th Sep 2020
The clinical trial is scheduled to start this month.
VXRT Stock: Vaxart Shoots Higher on Human Trial Approval
01:50pm, Monday, 14'th Sep 2020
Vaxart just announced it will begin enrolling participants in human trials of its coronavirus vaccine. VXRT stock is popping in response.
Why Vaxart Stock Is Crushing It Today
10:42am, Monday, 14'th Sep 2020
The FDA gave a green light for the biotech to begin phase 1 testing of its coronavirus vaccine candidate.
Vaxart's stock rallies 15% after it gets clearance to begin human trials of COVID-19 vaccine candidate
08:10am, Monday, 14'th Sep 2020
Shares of Vaxart Inc. VXRT, +10.87% jumped 15.6% in premarket trading on Monday after the company said it had received the go-ahead from the Food and Drug Administration to begin testing its experimen
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
08:00am, Monday, 14'th Sep 2020
Recruitment for Phase 1 clinical study expected to start this month
Better Coronavirus Stock: Altimmune or Vaxart?
06:14am, Saturday, 12'th Sep 2020
These biotechs are developing coronavirus vaccines with a twist.
San Francisco, California--(Newsfile Corp. - September 11, 2020) - Hagens Berman announces that it has filed a class action lawsuit against Vaxart, Inc.
San Francisco, California--(Newsfile Corp. - September 10, 2020) - Hagens Berman announces that it has filed a class action lawsuit against Vaxart, Inc.
2 Game-Changing Biotech Stocks That May Make You Rich
06:55am, Thursday, 10'th Sep 2020
From a painless vaccine to a method of fixing faulty genes, betting on these technologies may bring big rewards.
Investor Alert: Kaplan Fox Investigates Vaxart For Potential Securities Fraud
05:28pm, Wednesday, 09'th Sep 2020
NEW YORK, Sept. 9, 2020 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Vaxart, Inc.
San Francisco, California--(Newsfile Corp. - September 9, 2020) - Hagens Berman announces that it has filed a class action lawsuit against Vaxart, Inc.
Why These 3 Coronavirus-Related Stocks Plummeted More Than 35% in August
03:58pm, Tuesday, 08'th Sep 2020
Competition from heavy hitters spooked investors.
PreMarket Prep Stock Of The Day: Vaxart
12:47pm, Tuesday, 08'th Sep 2020
Amid the carnage in the technology sector over the last few sessions, the COVID-19 crisis has taken a backseat to a much-needed correction in the markets.
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
08:00am, Tuesday, 08'th Sep 2020
Triggering mucosal immunity may be crucial for effective protection against SARS-CoV-2 infection and transmission
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Vaxart, Inc. Investors of Important Deadline in Securities Class Action – VXRT
11:00am, Sunday, 06'th Sep 2020
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Vaxart, Inc. (NASDAQ: VXRT) between June 25, 2020 to July 25, 2020, inclusive (the
